In the Department of Surgical Oncology, we believe that the way to find better methods of treating cancer is to coordinate patient care with laboratory research. This approach has produced innovative clinical studies that have improved patient treatment methods. Our physicians make important discoveries in the war against cancer, analyze the information gathered in their treatment and research activities, and train the health professionals and scientists of tomorrow. One of the most important objectives of the Department is to bring to the patient the observations and advances made in the laboratories.
Our Department has membership in national cooperative clinical trials groups bringing together thousands of oncology specialists to collaborate in clinical research studies. These groups include Cancer and Leukemia Group B (CALGB) and American College of Surgeons Oncology Group (ACOSOG). The wealth of knowledge shared by these groups brings to our patients the most advanced treatment options currently available.
Currently active clinical trials include a treatment for dysplastic nevus (the most common precursor of melanoma), a melanoma vaccine for advanced melanoma, and a gene transfer therapy also for advanced melanoma. A vitamin that can be created synthetically was discovered during chemoprevention research studies. Now under FDA review for initiation of a clinical trial, it will initially be used against advanced breast cancer.
Questions regarding our clinical trials may be addressed to:
Cathleen Schaeffer, RN
Clinical Research Coordinator
Department of Surgical Oncology, MC820
University of Illinois at Chicago
1801 W. Taylor, Room 1E
Chicago, IL 60612